Siemens releases powerful MR gradients
Siemens Medical Systems this month announced the introduction of its new Quantum gradients as an option to users of the Iselin, NJ, vendor's Symphony 1.5-tesla and Harmony 1-tesla MRI scanners. The powerful gradients will serve as a platform for
Siemens Medical Systems this month announced the introduction of its new Quantum gradients as an option to users of the Iselin, NJ, vendor's Symphony 1.5-tesla and Harmony 1-tesla MRI scanners. The powerful gradients will serve as a platform for exploring new clinical applications for MRI, according to Hermann Requardt, president of the company's MR business unit.
The Quantum gradients are rated at 30 mtesla/m with a peak 125 tesla/m/sec slew rate and maximum 50-cm field-of-view. Achieving such specifications while maintaining the 60-cm apertures of the Symphony and Harmony magnet bores is a major accomplishment, the company said. Siemens believes that the gradients will improve clinical imaging parameters by 25% to 50%.
The gradients were featured in the MRI section of Siemens' booth at this month's European Congress of Radiology in Vienna. They require 510(k) certification from the Food and Drug Administration and thus are not yet commercially available in the U.S.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
